**Core Concept**
Sickle cell disease and hereditary spherocytosis are both characterized by red cell abnormalities. However, the key concept here is to identify which condition is most indicative of hemolysis, a process where red blood cells are destroyed faster than they can be made.

**Why the Correct Answer is Right**
The correct answer is **B. Elevated indirect bilirubin**. Elevated indirect bilirubin levels are a strong indicator of hemolysis. This is because indirect bilirubin is a byproduct of the breakdown of hemoglobin, which is released from red blood cells during hemolysis. The liver then converts indirect bilirubin to direct bilirubin, which is excreted in the bile. An elevated indirect bilirubin level suggests that the body is producing more bilirubin than it can process, which is a hallmark of hemolysis.

**Why Each Wrong Option is Incorrect**
**Option A:** **Sickle cell trait** is a benign condition where an individual inherits one normal hemoglobin gene and one sickle hemoglobin gene. This condition does not typically result in hemolysis. Individuals with sickle cell trait are generally asymptomatic and do not experience hemolysis.

**Option C:** **Target cells** are a morphological abnormality of red blood cells that can be seen in various conditions, including hemoglobinopathies and thalassemias. While target cells can be indicative of a red cell disorder, they are not as specific for hemolysis as elevated indirect bilirubin levels.

**Clinical Pearl / High-Yield Fact**
A key clinical correlation to remember is that elevated indirect bilirubin levels can also be seen in conditions other than hemolysis, such as liver dysfunction or biliary obstruction. Therefore, a complete evaluation of liver function and biliary status is essential when interpreting elevated indirect bilirubin levels.

**Correct Answer:** B. Elevated indirect bilirubin.